Calyx Releases CTMS v15.0
Calyx has announced the availability of Calyx CTMS v15.0, a trial management system aiming to reduce risk and improving efficiencies in clinical development.
Some of the features of CTMS v15.0 enable trial sponsors to:
- Manage clinical trials in today’s changing landscape with tools that address the complexities of traditional and decentralized clinical trials
- Centralize the operational data of current and historical trials into a single source
- Conduct monitoring visits anywhere, regardless of internet connectivity via the smartphone- accessible Calyx CTMS mobile application
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
